Cytotoxic T lymphocytes specific for self tumor immunoglobulin express T cell receptor delta chain.
Open Access
- 1 May 1989
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 169 (5), 1557-1564
- https://doi.org/10.1084/jem.169.5.1557
Abstract
CTL are thought to play a role in the elimination of transformed cells in vivo. The effectiveness of such CTL is in part dependent on recognition of tumor specific antigens. Among the best characterized tumor-specific antigens are the unique or idiotypic determinants on the Ig of B cell lymphomas. Here we describe the generation and properties of human CTL specific for the idiotype on autologous B cell tumors. These cells are CD3+,CD4-,CD8- and express the delta chain of the TCR. Such cells may prove useful in tumor-specific adoptive therapy.This publication has 26 references indexed in Scilit:
- Characteristics of a monoclonal antibody (WT-31) that recognizes a common epitope on the human T cell receptor for antigen.The Journal of Immunology, 1985
- A clinical trial of anti-idiotype therapy for B cell malignancyBlood, 1985
- Expression of T-cell antigen receptor genes during fetal development in the thymusNature, 1985
- Developmental regulation of T-cell receptor gene expressionNature, 1985
- Strategies for production of monoclonal anti-idiotype antibodies against human B cell lymphomas.The Journal of Immunology, 1984
- Complete primary structure of a heterodimeric T-cell receptor deduced from cDNA sequencesNature, 1984
- A DC-specific cytolytic T lymphocyte line is OKT8+1.The Journal of Immunology, 1983
- The functional significance, distribution, and structure of LFA-1, LFA-2, and LFA-3: cell surface antigens associated with CTL-target interactions.The Journal of Immunology, 1983
- Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype AntibodyNew England Journal of Medicine, 1982
- In vitro growth of lymphoma colonies from children with non-hodgkin's lymphomaCancer, 1981